Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Ramirez

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Disease|May 22, 2025
Comparison of clinicopathologic features and prognosis between surgically resected pulmonary large-cell neuroendocrine carcinoma and small-cell lung cancerYuke Mao, Hao Chang, Lu Wang, et al.
Journal of the American College of Surgeons|January 16, 2017
Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single InstitutionEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2012
Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancerRaymond U Osarogiagbon, Laura E Miller, Robert A Ramirez, et al.
Translational Lung Cancer Research|June 10, 2024
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring <i>EML4-ALK</i> rearrangementWenbin Hu, Jiaming Zhao, Guoxia Wang, et al.
Translational Lung Cancer Research|March 14, 2022
Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancerJie Dai, Xinsheng Zhu, Dianke Li, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
The Annals of Thoracic Surgery|September 27, 2013
Dual intervention to improve pathologic staging of resectable lung cancerRaymond U Osarogiagbon, Robert A Ramirez, Christopher G Wang, et al.
Ochsner Journal|December 13, 2017
Prognostic Factors in Typical and Atypical Pulmonary CarcinoidsRobert A Ramirez, David T Beyer, Anne E Diebold, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung CancerEric M Lander, Xuanyi Li, Li-Ching Huang, et al.
JAMA Network Open|January 19, 2022
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide TherapySatya Das, Aman Chauhan, Liping Du, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Disease|May 22, 2025
Comparison of clinicopathologic features and prognosis between surgically resected pulmonary large-cell neuroendocrine carcinoma and small-cell lung cancerYuke Mao, Hao Chang, Lu Wang, et al.
Journal of the American College of Surgeons|January 16, 2017
Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single InstitutionEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2012
Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancerRaymond U Osarogiagbon, Laura E Miller, Robert A Ramirez, et al.
Translational Lung Cancer Research|June 10, 2024
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring <i>EML4-ALK</i> rearrangementWenbin Hu, Jiaming Zhao, Guoxia Wang, et al.
Translational Lung Cancer Research|March 14, 2022
Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancerJie Dai, Xinsheng Zhu, Dianke Li, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
The Annals of Thoracic Surgery|September 27, 2013
Dual intervention to improve pathologic staging of resectable lung cancerRaymond U Osarogiagbon, Robert A Ramirez, Christopher G Wang, et al.
Ochsner Journal|December 13, 2017
Prognostic Factors in Typical and Atypical Pulmonary CarcinoidsRobert A Ramirez, David T Beyer, Anne E Diebold, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung CancerEric M Lander, Xuanyi Li, Li-Ching Huang, et al.
JAMA Network Open|January 19, 2022
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide TherapySatya Das, Aman Chauhan, Liping Du, et al.
Pageof 6